Cost assessment of treatment of acute myocardial infarction and angiographically visible coronary thrombus.

CONCLUSION: A complex pharmaco-interventional strategy, with glycoprotein IIb/IIIa inhibitor and MT, though more expensive, may prove cost-effective. PMID: 29376402 [PubMed - as supplied by publisher]
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Tags: J Comp Eff Res Source Type: research